(Guest Lecture): Relapsed Refractory Multiple Myeloma - Krina Patel, MD, MSc | RT Irvine, CA Nov 5, 2022

(Guest Lecture): Relapsed Refractory Multiple Myeloma - Krina Patel, MD, MSc | RT Irvine, CA Nov 5, 2022
(Guest Lecture) November 2022 - Integrative Medicine: Ideas for Myeloma Treatment
(Guest Lecture): November 2022 - How Myeloma Frontline Therapy is Changing - Ajai Chari, MD
(Guest Lecture): November 2022 - CAR-T: Ready for Prime Time?
(Guest Lecture) November 2022 - Physiatry: A New Approach Incorporating Proven Ideas
CAR-T: Ready for Prime Time? - Jesus Berdeja, MD | RT Irvine, CA Nov 5, 2022
Moderated Discussion and Round Table Audience Q&A One | RT Irvine, CA Nov 5, 2022
Round Table Audience Q&A Two | RT Irvine, CA Nov 5, 2022
Physiatry: A New Approach Incorporating Proven Ideas - Jessica Cheng, MD | RT Irvine, CA Nov 5, 2022
HealthTree Coach Program Discussion | RT Irvine, CA Nov 5, 2022
Amrita Krishnan Leads Faculty Discussion | RT Irvine, CA Nov 5, 2022
Pushing Toward Tomorrow - Amrita Krishnan, MD, FACP | RT Irvine, CA Nov 5, 2022
Integrative Medicine: Ideas for Myeloma Treatment - Richard Lee, MD | RT Irvine, CA Nov 5, 2022
Relapsed Refractory Multiple Myeloma - Krina Patel, MD, MSc | RT Irvine, CA Nov 5, 2022
How Myeloma Frontline Therapy is Changing - Ajai Chari, MD | RT Irvine, CA Nov 5, 2022
Is chemotherapy on the spinal cord ever used in adult AML?
Can natural killer cells become exhausted?
What are natural killer cells? What is their job? How do they differ from t-cells?
How are NK cells being used in anti-myeloma therapy?